Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with...
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients...
Shives, M.D., spoke with Justin Kreuter, M.D., Medical Director of Mayo’s Blood Donor Program, about new eligibility guidelines for blood donors with previous cancer diagnoses....
SelectAgent For Web On Demand Module 2023
SelectAgent For Web On Demand Module 2023 SelectAgent For Web On Demand Module 2023 You are offline...
your practice, and broaden access to specialized testing. Follow news about Mayo Clinic Laboratories here to be the first to know about new test launches and learn about operational updates that may affect...
your practice, and broaden access to specialized testing. Follow news about Mayo Clinic Laboratories here to be the first to know about new test launches and learn about operational updates that may affect...
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....